Vault-13

Aquilo Capital Management, LLC

SAN FRANCISCO, CA · CIK 1591986 · 13F filing filed 2024-02-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$142.6m reported value +29.2% vs Q3 2023
9positions
100.0%in top 10
2 new 1 added 4 reduced 5 sold out vs Q3 2023

Options: 0 call positions (— notional), 1 put positions ($17.9m notional) – listed below, not included above.

Holdings, Q4 2023

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ARROWHEAD PHARMACEUTICALS IN COM ARWR ARWR 908,474 $27.8m19.50% 19.50% UnchangedShares held: Q1 2023 1.0m, Q2 2023 858.5k, Q3 2023 908.5k, Q4 2023 908.5k
2 BLUEPRINT MEDICINES CORP COM BPMC BPMC 254,827 $23.5m16.48% 16.48% ReducedShares held: Q1 2023 622.8k, Q2 2023 449.0k, Q3 2023 379.1k, Q4 2023 254.8k -124.3k -124,263 -32.8%
3 KYMERA THERAPEUTICS INC COM KYMR KYMR 881,337 $22.4m15.74% 15.74% AddedShares held: Q1 2023 601.3k, Q2 2023 651.3k, Q3 2023 782.2k, Q4 2023 881.3k +99.1k +99,118 12.7%
4 ARVINAS INC COM ARVN ARVN 489,153 $20.1m14.12% 14.12% UnchangedShares held: Q1 2023 628.9k, Q2 2023 623.9k, Q3 2023 489.2k, Q4 2023 489.2k
5 SILENCE THERAPEUTICS PLC ADS SLN SLN 1,043,284 $18.1m12.71% 12.71% ReducedShares held: Q1 2023 1.3m, Q2 2023 1.3m, Q3 2023 1.3m, Q4 2023 1.0m -268.9k -268,949 -20.5%
6 REGENXBIO INC COM RGNX RGNX 802,424 $14.4m10.10% 10.10% ReducedShares held: Q1 2023 831.0k, Q2 2023 870.1k, Q3 2023 847.4k, Q4 2023 802.4k -45.0k -45,000 -5.3%
7 MERUS N V COM MRUS MRUS 355,109 $9.8m6.85% 6.85% ReducedShares held: Q1 2023 1.2m, Q2 2023 775.1k, Q3 2023 430.1k, Q4 2023 355.1k -75.0k -75,000 -17.4%
8 REPARE THERAPEUTICS INC COM RPTX RPTX 633,271 $4.6m3.24% 3.24% NewShares held: Q1 2023 0, Q2 2023 0, Q3 2023 0, Q4 2023 633.3k
9 SUTRO BIOPHARMA INC COM COM 420,649 $1.8m1.27% 1.27% NewShares held: Q1 2023 0, Q2 2023 0, Q3 2023 0, Q4 2023 420.6k

Sold out since Q3 2023

SecurityTickerShares held beforeValue then
C4 THERAPEUTICS INC CCCC CCCC 1,990,334 $3.7m2.0m shares
GENMAB A/S GMAB GMAB 52,148 $1.8m52.1k shares
ARGENX SE ARGX ARGX 3,715 $1.8m3.7k shares
OLEMA PHARMACEUTICALS INC OLMA OLMA 88,875 $1.1m88.9k shares
PIERIS PHARMACEUTICALS INC 3,303,190 $984.4k3.3m shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
SPDR SER TR XBI · Put XBIPut 200,000 $17.9m200.0k shares New